|
 News
Releases
|
|
Welch Allyn and Mortara
Instrument Announce Licensing Agreement
Welch Allyn adds world class VERITAS ECG
analysis technology to its innovative Acuity™ Central Monitoring
Station.
MILWAUKEE, WI, USA
19
December 2002
Welch Allyn Monitoring
and Mortara Instrument today announced they have signed a licensing
agreement that provides Welch Allyn Monitoring with access to Mortara
Instrument’s VERITAS cardiology technology for its Flexible Monitoring
care products.
"Welch Allyn Monitoring is fully committed to providing an innovative
line of reliable, state-of-the-art patient monitoring solutions for
today’s healthcare environment,” commented Rick Davis, vice president of
marketing for Welch Allyn Monitoring. “The inclusion of Mortara’s
world-class cardiac Arrhythmia recognition capability, along with
soon-to-be released enhanced tools, will enable us to become an even
stronger player in the cardiac arena. The recent introduction of the
Micropaq patient wearable monitor has made tremendous inroads into the
cardiac telemetry market.”
The licensing agreement allows for the integration of Mortara's VERITAS
ECG signal processing algorithms into Welch Allyn Monitoring’s Acuity
Central Monitoring Station. Both Mortara’s Arrhythmia Analysis algorithm
and ST Analysis algorithm will be included in the new software release.
The Acuity Central Monitoring Station offers the centralization of
essential vital sign parameters such as blood pressure, temperature,
pulse oximetry and capnography on one system. The system displays a
“blueprint” or map of each floor and care unit, indicating every
monitored patient’s location
with colored icons. The software records every beat of patient data for
96 hours, allowing
for easy record keeping.
“Through 20 years of continuous investment in ECG technology, Mortara
Instrument has created a wide array of leading ECG technology
components, both hardware and software, that are provided on an OEM
basis to numerous companies,” noted Justin L. Mortara, Ph.D., vice
president of sales and marketing for Mortara Instrument. “Welch Allyn
Monitoring’s market leadership extending ECG monitoring to
non-traditional areas outside of the ICU will ensure that our cardiology
expertise reaches more care areas to positively impact a greater number
of lives.”
Welch Allyn Monitoring expects to begin shipments of the Acuity Central
Monitoring System with version 5.40 software immediately.
About Welch Allyn Monitoring: Operated through Welch Allyn Protocol,
Inc.—a wholly owned subsidiary of Welch Allyn, Inc.—Welch Allyn
Monitoring designs, manufactures and markets mission-critical flexible
monitoring solutions that improve patient care and lower healthcare
operating costs. Welch Allyn Monitoring uses innovative computer
software technologies to provide vital patient data and connect
clinicians with mobile patients via workstations, wireless devices and
the Internet. Based in Beaverton, Oregon, Welch Allyn Monitoring
provides additional information on its products and services at
www.monitoring.welchallyn.com.
About Welch Allyn, Inc.: Welch Allyn, Inc. was founded in 1915 and is
today a leading manufacturer of innovative medical diagnostic equipment,
patient monitoring systems, and miniature precision lamps. Headquartered
in Skaneateles Falls, New York, USA, Welch Allyn employs more than 2,100
people and has numerous manufacturing, sales, and distribution
facilities located throughout the world. Additional information on Welch
Allyn and its products may be found at www.welchallyn.com.
About Mortara Instrument: Mortara Instrument's headquarters are located
in Milwaukee, WI, with European operations based in Bologna, Italy.
Mortara Instrument is distinguished in the field of non-invasive
cardiology for the innovations that are the core of the company's
complete line of ECG products. These product innovations include the
integration of 12-Lead ECG technology in bedside monitoring, wireless
stress testing, Holter and telemetry monitoring systems. The company's
web site is www.mortara.com.
For More Information Contact:
Robert Wilmington
Product Manager, Acuity Systems
Welch Allyn Monitoring
503- 530-7324
rwilmington@monitoring.welchallyn.com
Justin L. Mortara
Vice President Sales and Marketing
Mortara Instrument, Inc.
Milwaukee, WI
414-354-1600
justin.mortara@mortara.com
Micropaq and FlexNet are trademarks and Acuity is a registered trademark
of Welch Allyn Protocol, Inc.
For additional information about the VERITAS ECG algorithms or other
Mortara Instrument technology solutions, please send a message to
solutions@mortara.com or
visit the company website at
www.mortara.com
|
|
|
